Petrus Trust Company’s Bio-Rad Laboratories Class A BIO Stock Holding History

Petrus Trust Company’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,510	Closed	-$364K	–	215
2025 Q2	$364K	Sell	1,510 -1,314	-47%	-$311K	0.04%	235
2025 Q1	$688K	Buy	2,824 +1,186	+72%	+$357K	0.06%	97
2024 Q4	$538K	Buy	+1,638	New	+$556K	0.05%	190
2024 Q3	–	Sell	-1,620	Closed	-$442K	–	566
2024 Q2	$442K	Buy	+1,620	New	+$471K	0.04%	270
2024 Q1	–	Sell	-987	Closed	-$319K	–	638
2023 Q4	$319K	Buy	987 +147	+18%	+$46.1K	0.03%	407
2023 Q3	$301K	Sell	840 -1,673	-67%	-$645K	0.03%	386
2023 Q2	$953K	Buy	+2,513	New	+$1.02M	0.11%	30
2023 Q1	–	Sell	-1,235	Closed	-$519K	–	545
2022 Q4	$519K	Buy	1,235 +595	+93%	+$240K	0.07%	85
2022 Q3	$267K	Buy	+640	New	+$319K	0.04%	105

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Petrus Trust Company's BIO Position: Q3 2025 in Review

Petrus Trust Company sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2025, closing a stake of 1,510 shares — an estimated $364K sold.

Petrus Trust Company first reported a position in BIO in Q3 2022 and held it in 9 quarters. The position peaked at $953K in Q2 2023. 397 funds tracked by Wall St. Rank hold BIO as of Q3 2025.

Petrus Trust Company reported no remaining Bio-Rad Laboratories Class A position as of Q3 2025 after selling out during the quarter.
Petrus Trust Company sold 1,510 Bio-Rad Laboratories Class A shares in Q3 2025, an estimated $364K.
Petrus Trust Company first reported a position in Bio-Rad Laboratories Class A in Q3 2022 and held it in 9 quarters.
Petrus Trust Company's Bio-Rad Laboratories Class A position peaked at $953K in Q2 2023.
397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2025.

Based on Petrus Trust Company's 13F filing for Q3 2025, filed 14 Nov 2025.